VENTURE CAPITAL POST

Brazil increased bid price for Libra, the world's largest oil find from US$4.6 billion to US$7 billion.

After its rejection of the Amgen bid, Onyx is now fielding bids from Bayer and other pharmaceutical firms.

The New York Times Co received multiple bids for The Boston Globe according to sources familiar with the auction.

According to the German antitrust regulatory authority, the ownership of other service providers would delay and hamper Liberty Global's purchase of Kabel Deutschland.

According to sources, Icahn-backed Forest Laboratories is among mid-sized drug makers to eye for Elan.

With a US$1.1 billion offer for the Cermaq's fish feed unit, Bain Capital and Altor complicated Marine Harvest's plans of acquiring the entire firm with a US$1.7 billion deal.

According to sources, Vodafone considers to improve its bid for Kabel Deutschland after the said deal to purchase the company at Eur81 per share.

Rhoen-Klinikum that discussiins with Fresenius SE is not precursor to takeover.

Severn Trent rejection of the LongRiver consortium bid causes ripples in the mergers and acquisitions market as well as losses for hedge fund firms anticipating the buyout sale.

Royalty Pharma urged the federal court in New York to lift the temporary restraining order it has ordered for the Royalty-Elan bid.

LongRivers Partners to make a new bid for water utilities firm Severn Trent Plc.

Sprint overthrows US$3.40 bid per share of Dish to a US$4.40 bid per share for Clearwire.

Severn Trent rejects the new offer made by LongRiver consortium as it says it does not recognize the long term value and potential of the British water utilities firm.

ISS advises its shareholder clients to accept the bid of Softbank over Dish Network for Sprint.

Google may find itself in antiregulatory waters should it push its bid for Waze.